• Strong Robotic Performance Despite Lackluster Revenue from Changing Deal Mix
• Expanding Robotic Applications Contribute to Growth
• Other Orthopedic Robotics Moving Forward
• Orthopedic Enabling Tech Making Inroads into Spine and Vice Versa
• Navigation Highlights
• Advances in Augmented Reality
• Preoperative Planning Highlights

Orthopedic robotics market leader SYK reported that Q422 was a record quarter for MAKO installations, both in the US and internationally, with an unsurpassed number of MAKO installations in ASCs. In Q422, SYK saw ...

Read the entire Q422 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

• The Growing Interest in Biologic-Driven Soft Tissue Fixation
  • It was clear at AAOS that there is a growing interest among sports medicine companies and physicians in the use of biologic-driven soft tissue fixation. Since Smith+Nephew set the stage for ...
    
    
• Small and Mid-Size Players That Aim to Take Share
  • A number of smaller US and OUS-based soft tissue fixation companies were on display at AAOS showing that the market for soft tissue fixation is a popular one where new competitors see growth potential. Companies such as ...
    
    
• The New Companies Helping to Drive Innovation in Arthroscopic Video Technology
  
  • Arthroscopic video technology was front and center at AAOS 2023 from wireless cameras, disposable cameras and scopes to needle scope technology. While the big boys were showcasing their video technology as always, other companies, including ...

To read the complete "Sports Medicine and Arthroscopy Highlights at AAOS 2023" article by Andy Knapik, SmartTRAK's Senior Analyst, Soft Tissue Fixation and Arthroscopic Enabling Technologies, click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q422/FY22 AWC Market Recap* are:

• Complete Q422/FY22 AWC Market Overview and Highlights
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• WW Advanced Dressings: Continued Solid Growth
• Biologics: Growth Remains Healthy but Dips Slightly in Q422
  • Skin Substitutes/CTPs
  • Topical Delivery/Drug
  • Collagen/Active Dressings
  • Traditional NPWT Performance
  • Single-use NPWT Performance 
  • Topical Oxygen and Debridement
• Growth Analysis – Currency Having a Strong Impact Throughout 2022

The US went from 51.9% share market to 55.3% of the global AWC market, Europe from 29.5% to 26.4% and ROW from 18.6% to 18.3%. The primary reason is ...

Read the entire Q422/FY22 AWC Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q422 Extremities Market Recap* are:

• Complete Q422 Extremities Market Overview and Highlights
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• New Shoulder Products Driving Growth with More Tech Updates Coming
• Ankle Market Poised for Expansion with Next-Generation Implants and Technology
• Renewed Manufacturer Focus along with New Product Intros Fuel Upper Extremities Fixation
• Foot & Ankle Fixation Propelled by New Product Introductions
• Q422 Regulatory Highlights
  • Fixation
  • Shoulder Replacement
  • Elbow Replacement
  • Ankle Replacement
  • Toe Replacement
    

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Among the many topics covered in detail in our comprehensive Q422/FY22 OrthoBio Recap* are:

• Complete Q422 Trauma Market Overview and Highlights
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• US Bone Replacement
  • Good Momentum as Spine Rebounds and Products Launch
• US Cartilage Replacement
  • Procedure Volumes Stabilizing
• US Soft Tissue Replacement
  
  • Winter Months More Like a Sunny Day Rose Parade
• US Meniscus Replacement 
  • Growth Dampened by a Non-Blooming Group of Small Players

In addition to the previously mentioned market growth drivers, and as SmartTRAK highlighted in its latest trends article, “What Lies Ahead for Orthobiologics in 2023 and Beyond”,* other contributing factors of growth in 2022 and indicators of future growth in the US Orthobio market, included a tremendous level of M&As, strategic alliances and investments in new technologies. Overall, the US Orthobio market performed above expectations and ...

Read the entire Q422 Orthobio Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Rebecca Wilkins, DVP R&D Neuromodulation for Abbott, discusses the Eterna SCS, strategies for penetrating the market for PDN, the latest initiatives for DBS and DRG and what’s next for the Company in an interview with SmartTRAK.

Rebecca Wilkins, Divisional Vice President, Research and Development, Neuromodulation at Abbott, discusses Eterna, the Company’s newest rechargeable spinal cord stimulator, strategies for penetrating the market for painful diabetic neuropathy (PDN), the latest initiatives in deep brain stimulation and what’s next in terms of research and innovation an interview with SmartTRAK. 

To find out more, listen to the interview by clicking on the following video (19:41 min). A link to download a complete transcript of the interview is also provided below...just click Continue Reading.

Among the many topics covered in detail in our comprehensive Q422 Trauma Market Recap* are:

• Complete Q422 Trauma Market Overview and Highlights
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• Plates & Screws and IM Nails Propel Growth for the Quarter
• Globus Continues to Make Strides in Trauma Filling Out Product Portfolio
• Q422 Trauma Market Regulatory Highlights

The number one trauma player, DePuy Synthes* (46.6% Q4 US Trauma market share) attributed Q422 and full-year 2022 growth to market recovery along with market adoption of new introductions such as ...

Read the entire Q422 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

SmartTRAK reports on the Wound Care Today 2023 Conference, where a number of challenges facing UK Advanced Dressings companies were on display

The UK Advanced Dressings Market is projected to grow at a five-year compound annual growth rate (CAGR) of +1.9%, according to SmartTRAK estimates. The UK market is growing slower than any of the nine advanced dressings markets that SmartTRAK reports on, including the markets for Total Europe (+3.2%) and Worldwide (+5.0%). Given that the number of chronic wounds is increasing annually and the rate of UK inflation is in the double digits, why is the growth of the UK market so poor compared to other markets?

Among the may topics covered in detail in this comprehensive look into Wound Care 2023 article are:

• Increasing Alignment of Advanced Dressing Portfolios
• Increased Presence of Premium Priced Therapies
• Digital Tools That Highlight Inappropriate Usage of Dressings
• The Hidden Impact of Hidradenitis Suppurativa

Any usage of advanced dressings to manage HS is vulnerable to switching to products tailored to the condition. Quantifying the size of this market niche is challenging but could be an increasing area of focus in ...

To download and read the complete "Wound Care Today 2023: Low Growth Impacting the UK Advanced Dressings Market" perspective article by Kris Flinn, SmartTRAK's Senior Analyst, Wound, just click the button below.

Q422 saw a continued rise in procedure volumes globally which provided growth for the AT Disposables Market, which tends to trend with case volumes. On the capital side of the AT market, capital orders remained strong for items such as arthroscopic camera systems with new equipment purchases as well as an increasing need for replacement capital driving demand. However, supply chain and sterilization issues continue to hinder overall sales growth in both the consumable and capital sides of the Arthroscopic Technologies market.

Among the many topics covered in detail in our comprehensive Q422 Arthroscopic Technologies Market Recap* are: